Localization and Regulation of the Tissue Plasminogen Activator–Plasmin System in the Hippocampus

The extracellular protease cascade of tissue plasminogen activator (tPA) and plasminogen has been implicated in neuronal plasticity and degeneration. We show here that unstimulated expression of tPA in the mouse hippocampus is concentrated in the mossy fiber pathway, with little or no expression within the perforant path, the Schaffer collaterals, or neuronal cell bodies. tPA protein is also expressed in vascular endothelial cells throughout the brain parenchyma. Four hours after excitotoxic injury, tPA protein is transiently induced within CA1 pyramidal neurons. The induced CA1 tPA is localized to neurons that survive the injury and is enzymatically active. Within the mossy fiber pathway, injury resulted in decreased tPA protein. In contrast, mossy fiber tPA activity displayed a biphasic character: transient increase at 8 hr, then a decrease by 24 hr after injury. Analysis of plasminogen activator inhibitor-1 (PAI-1) expression showed that PAI-1 antigen is upregulated by 24 hr and could account for the tPA activity downregulation seen at this time point. Plasminogen immunohistochemistry suggested an increase within the mossy fiber pathway after injury. Finally, hippocampal tPA expression among various mammalian species was strikingly different. These results indicate a complex control of tPA protein and enzymatic activity in the hippocampus that may help regulate neuronal plasticity.

[1]  J. Roeper,et al.  Activity‐dependent formation of perforated synapses in cultured hippocampal neurons , 1999, The European journal of neuroscience.

[2]  P. Calabresi,et al.  Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory , 2000, The European journal of neuroscience.

[3]  E R Kandel,et al.  Reconstitution of the hippocampal mossy fiber and associational-commissural pathways in a novel dissociated cell culture system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Strickland,et al.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Mary Chen,et al.  Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway , 1998, Neuron.

[6]  G. Lynch,et al.  Activation of NMDA receptors stimulates extracellular proteolysis of cell adhesion molecules in hippocampus , 1998, Brain Research.

[7]  T. Bugge,et al.  Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. , 1995, Genes & development.

[8]  S. Tsirka,et al.  An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus , 1997, The Journal of Neuroscience.

[9]  T. Coleman,et al.  Neuroserpin, a Brain-associated Inhibitor of Tissue Plasminogen Activator Is Localized Primarily in Neurons , 1997, The Journal of Biological Chemistry.

[10]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[11]  D. Belin,et al.  Extracellular proteolysis in the adult murine brain. , 1993, The Journal of clinical investigation.

[12]  H. Nishino,et al.  Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  D. Jaworski,et al.  Regulation of tissue inhibitor of metalloproteinase‐3 (Timp‐3) mRNA expression during rat CNS development , 2000, Journal of neuroscience research.

[14]  R. Miskin,et al.  mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. , 1997, Brain research. Molecular brain research.

[15]  N. Seeds,et al.  Tissue plasminogen activator mRNA expression in granule neurons coincides with their migration in the developing cerebellum , 1995, The Journal of comparative neurology.

[16]  E. Quinlan,et al.  CPEB-Mediated Cytoplasmic Polyadenylation and the Regulation of Experience-Dependent Translation of α-CaMKII mRNA at Synapses , 1998, Neuron.

[17]  P. Greengard,et al.  Spinophilin regulates the formation and function of dendritic spines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Akassoglou,et al.  Tissue Plasminogen Activator–Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury , 2000, The Journal of cell biology.

[19]  Dominique Muller,et al.  Enhanced hippocampal long‐term potentiation and learning by increased neuronal expression of tissue‐type plasminogen activator in transgenic mice , 1999, The EMBO journal.

[20]  A. Basbaum,et al.  Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Sonderegger,et al.  Neuroserpin, an axonally secreted serine protease inhibitor. , 1996, The EMBO journal.

[22]  S. Strickland,et al.  Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  P. Carmeliet,et al.  Physiological consequences of loss of plasminogen activator gene function in mice , 1994, Nature.

[24]  W G Richards,et al.  The mouse tissue plasminogen activator gene 5' flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. , 1994, Development.

[25]  Friedman Gc,et al.  Tissue plasminogen activator mRNA expression in granule neurons coincides with their migration in the developing cerebellum. , 1995 .

[26]  A. Bignami,et al.  Plasminogen activators in rat neural tissues during development and in Wallerian degeneration , 2004, Acta Neuropathologica.

[27]  A. Ohtsuka,et al.  A novel serpin-like protein, B-43, exists in both neurons and astrocytes: an immunohistochemical study in the parietal region of the bovine brain , 1995, Neuroscience Letters.

[28]  D. Belin,et al.  Meiotic maturation of mouse oocytes triggers the translation and polyadenylation of dormant tissue-type plasminogen activator mRNA. , 1987, Genes & development.

[29]  K. Matsumoto,et al.  Serine Proteinase Inhibitor 3 and Murinoglobulin I Are Potent Inhibitors of Neuropsin in Adult Mouse Brain* , 2001, The Journal of Biological Chemistry.

[30]  C. Meliza,et al.  Real-time imaging of the axonal transport of granules containing a tissue plasminogen activator/green fluorescent protein hybrid. , 1998, Molecular biology of the cell.

[31]  P. Sonderegger,et al.  Neurotrypsin, a Novel Multidomain Serine Protease Expressed in the Nervous System , 1997, Molecular and Cellular Neuroscience.

[32]  P. Rakic,et al.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.

[33]  M. Chesselet,et al.  Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. , 1997, Brain research. Molecular brain research.

[34]  F. Sallés,et al.  A plasminogen activator is induced during goldfish optic nerve regeneration. , 1990, The EMBO journal.

[35]  P. Nelson,et al.  Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. , 1996, Journal of neurobiology.

[36]  Michael J. Cullen,et al.  Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40) , 1996, The Journal of Neuroscience.

[37]  Moses Rodriguez,et al.  MSP, a trypsin‐like serine protease, is abundantly expressed in the human nervous system , 2001, The Journal of comparative neurology.

[38]  S. Traynelis,et al.  Potentiation of NMDA Receptor Function by the Serine Protease Thrombin , 2000, The Journal of Neuroscience.

[39]  S. Strickland,et al.  Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin , 1997, Cell.

[40]  Eric R. Kandel,et al.  Tissue-plasminogen activator is induced as an immediate–early gene during seizure, kindling and long-term potentiation , 1993, Nature.

[41]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.

[42]  G. Akopian,et al.  Chronic Brain Oxidation in a Glutathione Peroxidase Knockout Mouse Model Results in Increased Resistance to Induced Epileptic Seizures , 2000, Experimental Neurology.

[43]  E. Kandel,et al.  Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Sidney Strickland,et al.  Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator , 1995, Nature.

[45]  G. Martin,et al.  mRNA localization studies suggest that murine FGF-5 plays a role in gastrulation. , 1991, Development.

[46]  S. Tsirka,et al.  Neuronal cell death and tPA , 1996, Nature.

[47]  S. Yoshida,et al.  Synaptic microenvironments — structural plasticity, adhesion molecules, proteases and their inhibitors , 2000, Neuroscience Research.

[48]  Akikazu Takada,et al.  Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection , 1999, Neuroscience Research.

[49]  W. Schleuning,et al.  Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis. , 1985, The Journal of biological chemistry.

[50]  Masanori Kato,et al.  Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues , 2001, Neuroscience Letters.

[51]  U. Frey,et al.  A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  N. Seeds,et al.  Plasminogen activator release at the neuronal growth cone. , 1981, Science.